Variant report

Variant	nsv609534
Chromosome Location	chr8:1777571-1810890
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:499)
CpG islands
(count:4034)
Chromatin interactive
region (count:23)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:499 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr8:1778106-1778154	K562	blood:	n/a	n/a
2	BACH1	chr8:1786794-1788094	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr8:1789055-1789249	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr8:1777228-1777861	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr8:1777522-1777722	K562	blood:	n/a	n/a
6	BACH1	chr8:1792557-1792581	K562	blood:	n/a	n/a
7	BCL3	chr8:1799220-1799673	GM12878	blood:	n/a	n/a
8	BCL3	chr8:1799177-1799567	GM12878	blood:	n/a	n/a
9	BCL3	chr8:1802840-1803070	GM12878	blood:	n/a	n/a
10	BCL3	chr8:1802755-1803054	GM12878	blood:	n/a	n/a
11	BHLHE40	chr8:1777502-1777862	K562	blood:	n/a	n/a
12	BRCA1	chr8:1792391-1792629	GM12878	blood:	n/a	n/a
13	BRCA1	chr8:1792449-1792452	HepG2	liver:	n/a	n/a
14	CBX3	chr8:1792450-1792695	K562	blood:	n/a	n/a
15	CCNT2	chr8:1777538-1777751	K562	blood:	n/a	n/a
16	CCNT2	chr8:1794192-1794427	K562	blood:	n/a	n/a
17	CEBPB	chr8:1803442-1803770	K562	blood:	n/a	n/a
18	CEBPB	chr8:1791838-1791972	HepG2	liver:	n/a	chr8:1791884-1791895
19	CHD2	chr8:1792600-1792732	HepG2	liver:	n/a	n/a
20	CHD2	chr8:1792554-1792562	Hela-S3	cervix:	n/a	n/a
21	CHD2	chr8:1789068-1789300	H1-hESC	embryonic stem cell:	n/a	n/a
22	CTCF	chr8:1785809-1785988	H1-hESC	embryonic stem cell:	n/a	chr8:1785903-1785916 chr8:1785900-1785918
23	CTCF	chr8:1784989-1785040	Kidney_OC	kidney:	n/a	n/a
24	CTCF	chr8:1795840-1795990	NHDF-neo	bronchial:	n/a	n/a
25	CTCF	chr8:1789100-1789250	AoAF	blood vessel:	n/a	n/a
26	CTCF	chr8:1789155-1789237	A549	lung:	n/a	n/a
27	CTCF	chr8:1795800-1795950	AoAF	blood vessel:	n/a	n/a
28	CTCF	chr8:1798237-1798311	GM20000	blood:	n/a	n/a
29	CTCF	chr8:1788980-1789130	HCM	heart:	n/a	n/a
30	CTCF	chr8:1789080-1789230	HMEC	breast:	n/a	n/a
31	CTCF	chr8:1789140-1789290	AG04449	skin:	n/a	n/a
32	CTCF	chr8:1789080-1789230	WERI-Rb-1	eye:	n/a	n/a
33	CTCF	chr8:1785800-1785950	HepG2	liver:	n/a	chr8:1785903-1785916 chr8:1785900-1785918
34	CTCF	chr8:1785869-1785968	HepG2	liver:	n/a	chr8:1785903-1785916 chr8:1785900-1785918
35	CTCF	chr8:1785869-1785946	Hela-S3	cervix:	n/a	chr8:1785903-1785916 chr8:1785900-1785918
36	CTCF	chr8:1777700-1777850	SAEC	small airway:	n/a	n/a
37	CTCF	chr8:1777740-1777890	HBMEC	blood vessel:	n/a	n/a
38	CTCF	chr8:1787915-1787921	H1-hESC	embryonic stem cell:	n/a	n/a
39	CTCF	chr8:1789180-1789330	HCT-116	colon:	n/a	n/a
40	CTCF	chr8:1795780-1795930	AG10803	skin:	n/a	n/a
41	CTCF	chr8:1795700-1795850	HAc	cerebellar:	n/a	n/a
42	CTCF	chr8:1787882-1787910	H1-hESC	embryonic stem cell:	n/a	n/a
43	CTCF	chr8:1795780-1795930	HEEpiC	esophagus:	n/a	n/a
44	CTCF	chr8:1777700-1777850	AoAF	blood vessel:	n/a	n/a
45	CTCF	chr8:1795780-1795930	NHDF-neo	bronchial:	n/a	n/a
46	CTCF	chr8:1785800-1785950	WERI-Rb-1	eye:	n/a	chr8:1785903-1785916 chr8:1785900-1785918
47	CTCF	chr8:1777740-1777890	HPAF	blood vessel:	n/a	n/a
48	CTCF	chr8:1789140-1789290	HCPEpiC	choroid plexus:	n/a	n/a
49	CTCF	chr8:1785836-1785990	K562	blood:	n/a	chr8:1785903-1785916 chr8:1785900-1785918
50	CTCF	chr8:1785800-1785950	HCPEpiC	choroid plexus:	n/a	chr8:1785903-1785916 chr8:1785900-1785918

(count:4034 , 50 per page) page: 1 2 3 4 5 6 7 ... 81

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:1783980-1784030	AG09309	skin:	n/a
2	chr8:1780242-1780292	Hela-S3	cervix:	n/a
3	chr8:1797886-1797936	HCM	heart:	n/a
4	chr8:1792615-1792665	NB4	blood:	n/a
5	chr8:1783358-1783408	CMK	blood:	n/a
6	chr8:1780242-1780292	GM12878	blood:	n/a
7	chr8:1790793-1790843	RPTEC	kidney:	n/a
8	chr8:1794627-1794677	T-47D	breast:	n/a
9	chr8:1783980-1784030	AG09309	skin:	n/a
10	chr8:1780242-1780292	Hela-S3	cervix:	n/a
11	chr8:1797886-1797936	HCM	heart:	n/a
12	chr8:1792615-1792665	NB4	blood:	n/a
13	chr8:1783358-1783408	CMK	blood:	n/a
14	chr8:1780242-1780292	GM12878	blood:	n/a
15	chr8:1790793-1790843	RPTEC	kidney:	n/a
16	chr8:1794627-1794677	T-47D	breast:	n/a
17	chr8:1798729-1798779	BJ	skin:	n/a
18	chr8:1792615-1792665	ProgFib	skin:	n/a
19	chr8:1779056-1779106	MCF10A-Er-Src	breast:	n/a
20	chr8:1797917-1797967	GM12878	blood:	n/a
21	chr8:1787467-1787517	AG04450	lung:	fetal
22	chr8:1809112-1809162	ovcar-3	ovarian:	n/a
23	chr8:1785833-1785883	HIPEpiC	eye:	n/a
24	chr8:1796506-1796556	HUVEC	blood vessel:	n/a
25	chr8:1810297-1810347	GM12892	blood:	n/a
26	chr8:1792758-1792808	HRCEpiC	kidney:	n/a
27	chr8:1792023-1792073	NB4	blood:	n/a
28	chr8:1786072-1786122	HRCEpiC	kidney:	n/a
29	chr8:1807280-1807330	MCF10A-Er-Src	breast:	n/a
30	chr8:1798785-1798835	SK-N-SH_RA	brain:	n/a
31	chr8:1789288-1789338	GM12878	blood:	n/a
32	chr8:1786072-1786122	NH-A	brain:	n/a
33	chr8:1807061-1807111	NB4	blood:	n/a
34	chr8:1780324-1780374	HNPCEpiC	eye:	n/a
35	chr8:1790861-1790911	HNPCEpiC	eye:	n/a
36	chr8:1792758-1792808	HMEC	breast:	n/a
37	chr8:1796568-1796618	BJ	skin:	n/a
38	chr8:1792775-1792825	RPTEC	kidney:	n/a
39	chr8:1797445-1797495	HEK293	kidney:	embryo
40	chr8:1796429-1796479	GM12878	blood:	n/a
41	chr8:1798729-1798779	ProgFib	skin:	n/a
42	chr8:1789537-1789587	CMK	blood:	n/a
43	chr8:1807575-1807625	HUVEC	blood vessel:	n/a
44	chr8:1807575-1807625	AG04450	lung:	fetal
45	chr8:1797886-1797936	CMK	blood:	n/a
46	chr8:1799142-1799192	AG09309	skin:	n/a
47	chr8:1789169-1789219	CMK	blood:	n/a
48	chr8:1792249-1792299	NHBE	bronchial:	n/a
49	chr8:1796676-1796726	AoSMC	blood vessel:	n/a
50	chr8:1790905-1790955	SK-N-SH	brain:	n/a

(count:23 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr8:1778222..1780570-chr8:1782075..1784994,4	MCF-7	breast:
2	chr19:39574470..39577467-chr8:1791052..1792928,2	MCF-7	breast:
3	chr8:1804701..1806345-chr8:1808982..1810841,2	MCF-7	breast:
4	chr8:1790802..1792919-chr8:1794714..1797248,2	K562	blood:
5	chr8:1784051..1785744-chr8:1790168..1791878,2	MCF-7	breast:
6	chr8:1731431..1734296-chr8:1777100..1779564,2	MCF-7	breast:
7	chr8:1791902..1793927-chr8:1800796..1802494,2	K562	blood:
8	chr8:1770355..1772056-chr8:1783670..1785482,2	MCF-7	breast:
9	chr8:1703592..1705221-chr8:1778659..1781628,2	MCF-7	breast:
10	chr8:1784051..1785744-chr8:1790168..1791878,2	MCF-7	breast:
11	chr8:1711323..1713781-chr8:1804428..1806395,2	MCF-7	breast:
12	chr8:1804701..1806345-chr8:1808982..1810841,2	MCF-7	breast:
13	chr8:1771136..1772958-chr8:1777807..1779958,2	K562	blood:
14	chr8:1791902..1794095-chr8:1800796..1802523,2	K562	blood:
15	chr8:1790802..1792919-chr8:1794714..1797248,2	K562	blood:
16	chr8:1778222..1780570-chr8:1782075..1784994,4	MCF-7	breast:
17	chr8:1770343..1774803-chr8:1776185..1779512,9	MCF-7	breast:
18	chr8:1792966..1795761-chr8:1797297..1800005,2	MCF-7	breast:
19	chr8:1792966..1795761-chr8:1797297..1800005,2	MCF-7	breast:
20	chr8:1791902..1794095-chr8:1800796..1802523,2	K562	blood:
21	chr8:1809191..1811307-chr8:1819741..1822402,2	K562	blood:
22	chr8:1710415..1713375-chr8:1784468..1786850,2	MCF-7	breast:
23	chr8:1791902..1793927-chr8:1800796..1802494,2	K562	blood:

No data

Variant related genes	Relation type
ARHGEF10	TF binding region
ARHGEF10	CpG island
ENSG00000182372	chromatin interactions
ENSG00000253982	chromatin interactions
ENSG00000183760	chromatin interactions
ENSG00000104728	chromatin interactions

Extended variants
information (count: 2360 )
Associated
traits (count: 119 )

Variant overlapped rSNPs/rCNVs (count:2360 , 50 per page) page: 1 2 3 4 5 6 7 ... 48

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs17064297	chr8:1777571-1777572	Enhancers Genic enhancers Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs555891661	chr8:1777590-1777591	Enhancers Genic enhancers Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs575856625	chr8:1777598-1777599	Enhancers Genic enhancers Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs368634405	chr8:1777607-1777608	Enhancers Genic enhancers Flanking Active TSS Weak transcription Transcr. at gene 5' and 3' Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs544597690	chr8:1777722-1777723	Enhancers Genic enhancers Flanking Active TSS Weak transcription Transcr. at gene 5' and 3' Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs187844596	chr8:1777738-1777739	Enhancers Genic enhancers Flanking Active TSS Weak transcription Transcr. at gene 5' and 3' Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs62477466	chr8:1777750-1777751	Enhancers Genic enhancers Flanking Active TSS Weak transcription Transcr. at gene 5' and 3' Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs62477467	chr8:1777815-1777816	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs118127531	chr8:1777816-1777817	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs192369137	chr8:1777821-1777822	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs549212012	chr8:1777845-1777846	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs184007007	chr8:1777880-1777881	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs531338292	chr8:1777894-1777895	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs370232382	chr8:1777902-1777903	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs187697179	chr8:1777906-1777907	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs149022673	chr8:1777908-1777909	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs533800552	chr8:1777931-1777932	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs547679953	chr8:1777932-1777933	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs192712749	chr8:1777963-1777964	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs536445264	chr8:1777984-1777985	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs556424240	chr8:1777989-1777990	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs143029230	chr8:1777993-1777994	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs538361092	chr8:1778005-1778006	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs558133718	chr8:1778014-1778015	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs577976530	chr8:1778017-1778018	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs540306870	chr8:1778021-1778022	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs554442327	chr8:1778030-1778031	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs17756457	chr8:1778046-1778047	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs542796955	chr8:1778095-1778096	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs562758049	chr8:1778105-1778106	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs531278100	chr8:1778132-1778133	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs544706670	chr8:1778142-1778143	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs564687444	chr8:1778155-1778156	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs78406831	chr8:1778161-1778162	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs543995844	chr8:1778168-1778169	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs114807465	chr8:1778169-1778170	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs28712194	chr8:1778193-1778194	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs530053996	chr8:1778195-1778196	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs549971789	chr8:1778236-1778237	Enhancers Genic enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs576939696	chr8:1778237-1778238	Enhancers Genic enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs569866568	chr8:1778244-1778245	Enhancers Genic enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs386720685	chr8:1778353-1778354	Enhancers Genic enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs188510927	chr8:1778354-1778355	Enhancers Genic enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs571695251	chr8:1778372-1778373	Enhancers Genic enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs75544732	chr8:1778390-1778391	Enhancers Genic enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs11267178	chr8:1778403-1778404	Enhancers Genic enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs553913081	chr8:1778426-1778427	Enhancers Genic enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs542175105	chr8:1778428-1778429	Enhancers Genic enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs143903358	chr8:1778429-1778430	Enhancers Genic enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs574239498	chr8:1778433-1778434	Enhancers Genic enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:119)

Disease	PMID	Source
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Congenital diaphragmatic hernia	21341218	CNVD
Cancer	18840272	CNVD
Pilocytic astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	16573809	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
abnormal development	18461090	CNVD
Crohn''s disease	19220326	CNVD
Psoriasis	19220326	CNVD
Prostate cancer	21965145	CNVD
Prostate cancer	18515986	CNVD
Chronic obstructive pulmonary disease	20378733	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	17603634	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Ovarian cancer	20844748	CNVD
Cervical cancer	17311676	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Schizophrenia	20877625	CNVD
Disorders of sex development	21048976	CNVD
Colorectal cancer	16272173	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	17001317	CNVD
Thyroid cancer	19087340	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Cancer	20164919	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
Ductal carcinoma	22052326	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Epilepsy	22083797	CNVD
Acute myeloid leukemia	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Breast cancer	20932292	CNVD
Congenital diaphragmatic hernia	21064195	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Ependymoma	20639864	CNVD
Ovarian cancer	22355333	CNVD
Tetralogy of Fallot	22912587	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Lung adenocarcinoma	21935476	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:1372 , 50 per page) page: 1 2 3 4 5 6 7 ... 28

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:1772800-1780000	Weak transcription	Hela-S3	cervix
2	chr8:1772800-1789400	Weak transcription	Rectal Mucosa Donor 29	rectum
3	chr8:1772800-1790800	Weak transcription	HSMMtube	muscle
4	chr8:1772800-1791400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr8:1773000-1778200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr8:1773800-1780400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
7	chr8:1773800-1780800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
8	chr8:1774000-1777600	Weak transcription	A549	lung
9	chr8:1774000-1781600	Weak transcription	Fetal Intestine Small	intestine
10	chr8:1774000-1789200	Weak transcription	Rectal Smooth Muscle	rectum
11	chr8:1774000-1845000	Weak transcription	Sigmoid Colon	Sigmoid Colon
12	chr8:1774600-1790200	Weak transcription	Colonic Mucosa	Colon
13	chr8:1774800-1777600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
14	chr8:1774800-1780400	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
15	chr8:1774800-1783400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
16	chr8:1774800-1786000	Weak transcription	NHDF-Ad	bronchial
17	chr8:1775000-1777600	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
18	chr8:1775000-1777800	Genic enhancers	H1 Cell Line	embryonic stem cell
19	chr8:1775000-1782200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
20	chr8:1775000-1782400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
21	chr8:1775000-1788800	Weak transcription	Fetal Brain Female	brain
22	chr8:1775000-1790400	Weak transcription	Brain Germinal Matrix	brain
23	chr8:1775200-1777600	Weak transcription	Brain Angular Gyrus	brain
24	chr8:1775200-1792400	Weak transcription	Fetal Lung	lung
25	chr8:1775400-1778200	Weak transcription	Brain Substantia Nigra	brain
26	chr8:1775400-1779800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
27	chr8:1775400-1780400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
28	chr8:1775400-1782000	Weak transcription	Cortex derived primary cultured neurospheres	brain
29	chr8:1775400-1782200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
30	chr8:1775800-1778400	Genic enhancers	HUES64 Cell Line	embryonic stem cell
31	chr8:1775800-1778400	Enhancers	Breast Myoepithelial Primary Cells	Breast
32	chr8:1776000-1777800	Weak transcription	Brain Cingulate Gyrus	brain
33	chr8:1776000-1778600	Enhancers	HUVEC	blood vessel
34	chr8:1776200-1778400	Enhancers	Ovary	ovary
35	chr8:1776200-1779400	Genic enhancers	ES-UCSF4 Cell Line	embryonic stem cell
36	chr8:1776400-1779000	Enhancers	ES-I3 Cell Line	embryonic stem cell
37	chr8:1776600-1779000	Weak transcription	H9 Cell Line	embryonic stem cell
38	chr8:1777000-1777600	Genic enhancers	Fetal Adrenal Gland	Adrenal Gland
39	chr8:1777000-1777600	Enhancers	Osteobl	bone
40	chr8:1777000-1778400	Enhancers	Adipose Nuclei	Adipose
41	chr8:1777000-1780000	Strong transcription	Fetal Stomach	stomach
42	chr8:1777200-1777600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
43	chr8:1777200-1777600	Transcr. at gene 5' and 3'	HUES6 Cell Line	embryonic stem cell
44	chr8:1777200-1777600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
45	chr8:1777200-1777600	Transcr. at gene 5' and 3'	Foreskin Keratinocyte Primary Cells skin02	Skin
46	chr8:1777200-1777600	Strong transcription	Foreskin Melanocyte Primary Cells skin01	Skin
47	chr8:1777200-1777800	Genic enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
48	chr8:1777200-1777800	Genic enhancers	Right Ventricle	heart
49	chr8:1777200-1778000	Weak transcription	HUES48 Cell Line	embryonic stem cell
50	chr8:1777200-1778000	Genic enhancers	iPS DF 6.9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links